Legal

The FDA is cracking down on telemedicine companies and online retailers for illegally marketing compounded weight loss drugs like semaglutide. This article details key violations, including false claims of FDA approval and misleading use of "generic" terminology, helping independent pharmacies understand the regulatory risks. Pharmacy owners can use this information to ensure their compounding and marketing practices remain strictly compliant with FDA guidelines.

Tennessee's FairRx Act is exposing CVS Health's aggressive tactics to maintain its PBM dominance, including dark-money ads and unauthorized patient texts. The legislation aims to prevent PBMs from owning the pharmacies they reimburse, creating a potential model for nationwide reform. Independent pharmacies can learn from this powerful coalition of lawmakers, regulators, and pharmacists fighting back against vertically integrated healthcare empires.